Skip to content

The effects of remimazolam and dexmedetomidine on postoperative agitation and delirium in elderly patients undergoing thoracoscopic surgery

The effects of remimazolam and dexmedetomidine on postoperative agitation and delirium in elderly patients undergoing thoracoscopic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101977
Enrollment
Unknown
Registered
2025-05-06
Start date
2025-05-06
Completion date
Unknown
Last updated
2025-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung tumor

Interventions

Remimazolam group:General anesthesia was induced with sevoflurane and remifentanil, and maintained with remifentanil. Remifentanil was continuously pumped at a rate of 0.5 mg·kg-1·hr-1 from 3 minutes
The dexmedetomidine group:General anesthesia was induced by sevoflurane, remifentanil and dexmedetomidine. Dexmedetomidine was continuously pumped at a rate of 0.5 ug ·kg-1·hr-1 from 3 minutes before

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Patients scheduled for elective unilateral thoracoscopic surgery; (2) Age >= 65 years; (3) ASA classification: I-III grade;

Exclusion criteria

Exclusion criteria: (1) BMI less than 18 kg/m^2 or BMI greater than 30 kg/m^2; (2) Patients with language comprehension disorders, mental illness and other conditions that prevent cooperation; (3) Ejection fraction of the heart less than 40%, heart rate less than 50/min, arrhythmias other than first-degree atrioventricular block; (4) Liver and kidney dysfunction; (5) Epilepsy and related mental and cognitive functional disorders, long-term stress stimulation or psychological disorders; (6) History of alcohol abuse, dependence on analgesic drugs and long-term use of sedatives; (7) Allergic to the study drug; (8) Those who do not sign the informed consent form. ;

Design outcomes

Primary

MeasureTime frame
Postoperative delirium;Postoperative agitation;

Secondary

MeasureTime frame
Postoperative QoR-15 Quality of Recovery Score;Postoperative NRS pain score;Postoperative sleep scale score;The incidence of intraoperative hypotension and heart rate < 50;The time from the end of the surgery to extubation, and the duration of stay in the PACU;Time of removal of thoracic drainage tube, Postoperative hospital stay duration;

Countries

China

Contacts

Public ContactYan Ming

The Affiliated Hospital of Xuzhou Medical University

yjy3001@163.com+86 180 5226 8329

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026